Covid-19: Therapy adverts banned over claims they could treat long Covid

A trio of adverts for acupuncture and craniosacral therapists have been banned for misleading people about treating long Covid.

A paid-for Facebook ad and an Instagram post for Jo Llewellyn, a craniosacral therapist, included the claim that craniosacral therapists treat long Covid, while an Instagram post for Peachy Acupuncture read: “Long Covid at its worst is life changing and debilitating. Gentle acupuncture and B12 shots can chip away at the fatigue, brain fog and gut issues to support healing.”

A Facebook advert and website for Serenity Acupuncture, in Bude, also said acupuncture could be used to treat long Covid.

The Advertising Standards Authority investigated the ads as part of its wider work on long Covid treatments following intelligence gathered by the watchdog.

Jo Llewellyn said many of their clients had symptoms of long Covid, but were all under the supervision of their doctors.

Following notification of the investigation by the ASA, they acknowledged that they had “underestimated the level of evidence that was required” to make efficacy claims about their treatment and long Covid, and had removed the ads.

The ASA said: “We considered consumers would understand the ads to mean that craniosacral therapy was an effective treatment for long Covid. We therefore expected to see robust scientific evidence to substantiate the claims.

“We had seen no evidence to demonstrate the efficacy of craniosacral therapy as a treatment for long Covid.

“Whilst we welcomed Jo Llewellyn Craniosacral Therapist’s willingness to remove the posts, in the absence of such evidence, we concluded the ads were misleading and therefore breached the Code.”

Peachy Acupuncture said they were careful about the wording they used in the ad and did not say they could cure long Covid, adding that there was “significant evidence” that acupuncture could help reduce symptoms.

But the ASA said: “We considered consumers would understand the ad to mean that acupuncture could contribute to the treatment of long Covid, and in particular the symptoms including fatigue, brain fog and gastrointestinal issues. We therefore expected to see robust scientific evidence to substantiate the claims.”

It said it “did not consider that the evidence met the standard we required for the type of claim being made”.